Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Alteogen, Altimmune, Aptevo, Avita Medical, Berlin Cures, Biosig, Cadila, Cancer Research UK, CARB-X, Catalent, Daiichi Sankyo, Eli Lilly, Emergent, Entos, Everinsight, Gilead Sciences, Ignova, Immuneering, Immunomic, Immunoprecise Antibodies, International Business Machines, Inxmed, JS Innomed, Lion TCR, Mateon, Melior, Moderna, Novartis, Oncology Venture, Otsuka, Palatin, Peel, Pfizer, Pharmabcine, Renibus, Repertoire Immune Medicines, Replicate, Schrödinger, Taiho, Takeda, Thermo Fisher, Vaxart, Vistagen, Vitrac, Wuxi.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Arch Biopartners, Bioaegis, Hutchison China Meditech, Translate Bio, Takeda.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aerus, Ancora Heart, Corelink, Endra Life Sciences, Illuminoss Medical, Kardium, Livsmed, Qure.ai, Seegene.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cvrx, Datos Health, Genetron, Reneuron.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Activ Surgical, Alberta Health Services, Ambu, Ascom, Biocorp, Blueprint Medicines, Ci Security, Coeus Consulting, C-Rad, Cylera, Dermtech, Endbraincancer Initiative, Flir Systems, Forest Devices, Fuel Medical Group, Gt Medical Technologies, Helferapp, Humana, Innominds Software, Ion Beam Applications, Labcorp, Leica Microsystems, Luminex, Medigate, Mindmaze, Novavision, Mirador Global, Mobidiag, Ordr, Oxitone Medical, Plano, Pra Health Sciences, Pressure Biosciences, Proscia, Protxx, Quest Diagnostics, Roche, Royal Philips, Santen Pharmaceutical, Sauber Engineering, Stryker, Trialjectory, Twist Bioscience, Vericel, Vycor Medical, Walmart, Wright Medical Group.

Med-tech firms raising money in public or private financings, including: Guided Therapeutics, Oncology Venture, Overjet, Predictive Oncology, Tara Biosystems, Transenterix.

New hires and promotions in the med-tech industry, including: Daxor, Sarepta Therapeutics, Siren Care, Subiomed.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alterity, Ardelyx, Astrazeneca, Bioinvent, Mediwound, Merck, Nuvox, Oncopeptides, Oncternal, Osmotica, Prestige, Sparingvision, Synthetic Biologics, Vericel, Verrica.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanced Accelerator, Audentes, Basilea, Bioasis, Blueprint, Burning Rock, Camino, CNS, Cstone, Genespire, Hoth, Immatics, Marker, Meissa, Novartis, Optinose, Vertex, Ziphius.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alnylam, Altimmune, Amniox, Aobiome, Beyondspring, Blueprint, Can-Fite, Depuy, Exelixis, Galectin, Genmab, Humanigen, Impel, Inovio, Iveric, Marinus, Meissa, Nordic Nanovector, Novartis, Noxxon, Oncternal, Orexo, Orthocell, Reneuron, Revance, Rheacell, Roche, Rubius, Seattle Genetics, Zynerba.